This discrepancy with some previous reports [13] may reflect our population’s more advanced CKD with uniformly elevated MCP-1 levels, which may have limited discriminative ability for mortality risk, combined with our shorter follow-up period. Here, CCL2 is linked to chronic kidney disease.